Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.55 USD | 0.00% | +4.51% | +4.94% |
May. 15 | Athira Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Athira Pharma, Inc. Appoints Javier San Martin, M.D., as Chief Medical Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 97.74M |
---|---|---|---|---|---|
Net income 2024 * | -108M | Net income 2025 * | -134M | EV / Sales 2024 * | - |
Net cash position 2024 * | 254M | Net cash position 2025 * | 172M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.06
x | P/E ratio 2025 * |
-1.12
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.25% |
Latest transcript on Athira Pharma, Inc.
Current month | -2.67% | ||
1 month | +20.28% | ||
3 months | -28.77% | ||
6 months | +29.44% | ||
Current year | +4.94% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Litton
CEO | Chief Executive Officer | 56 | 19-07-10 |
Andrew Gengos
DFI | Director of Finance/CFO | 59 | 23-05-17 |
Rachel Lenington
COO | Chief Operating Officer | 51 | 21-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 56 | 22-01-26 |
John Fluke
BRD | Director/Board Member | 81 | 12-12-31 |
Joseph Edelman
BRD | Director/Board Member | 67 | 20-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.72% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 2.55 | 0.00% | 70,102 |
24-06-10 | 2.55 | 0.00% | 171,136 |
24-06-07 | 2.55 | +0.39% | 198,177 |
24-06-06 | 2.54 | -1.17% | 258,495 |
24-06-05 | 2.57 | +5.33% | 166,957 |
Delayed Quote Nasdaq, June 11, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.94% | 97.74M | |
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |
- Stock Market
- Equities
- ATHA Stock